• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于粗粒分子动力学的免疫信息学解释 SARS-CoV-2 肽基疫苗发现中细胞毒性 T 细胞表位的结合子和非结合子分类。

Coarse-grained molecular dynamics-guided immunoinformatics to explain the binder and non-binder classification of Cytotoxic T-cell epitope for SARS-CoV-2 peptide-based vaccine discovery.

机构信息

Faculty of Mathematics and Natural Sciences, Department of Chemistry, Universitas Padjadjaran, Bandung, West Java, Indonesia.

Research Center for Molecular Biotechnology and Bioinformatics, Universitas Padjadjaran, Bandung, West Java, Indonesia.

出版信息

PLoS One. 2023 Oct 5;18(10):e0292156. doi: 10.1371/journal.pone.0292156. eCollection 2023.

DOI:10.1371/journal.pone.0292156
PMID:37796941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10553366/
Abstract

Epitope-based peptide vaccine can elicit T-cell immunity against SARS-CoV-2 to clear the infection. However, finding the best epitope from the whole antigen is challenging. A peptide screening using immunoinformatics usually starts from MHC-binding peptide, immunogenicity, cross-reactivity with the human proteome, to toxicity analysis. This pipeline classified the peptides into three categories, i.e., strong-, weak-, and non-binder, without incorporating the structural aspect. For this reason, the molecular detail that discriminates the binders from non-binder is interesting to be investigated. In this study, five CTL epitopes against HLA-A02:01 were identified from the coarse-grained molecular dynamics-guided immunoinformatics screening. The strong binder showed distinctive activities from the non-binder in terms of structural and energetic properties. Furthermore, the second residue from the nonameric peptide was most important in the interaction with HLA-A02:01. By understanding the nature of MHC-peptide interaction, we hoped to improve the chance of finding the best epitope for a peptide vaccine candidate.

摘要

基于表位的肽疫苗可以引发针对 SARS-CoV-2 的 T 细胞免疫反应,从而清除感染。然而,从整个抗原中找到最佳表位是具有挑战性的。免疫信息学中的肽筛选通常从 MHC 结合肽、免疫原性、与人类蛋白质组的交叉反应性以及毒性分析开始。该流水线将肽分为强结合、弱结合和非结合三类,而不考虑结构方面。出于这个原因,区分结合物和非结合物的分子细节很有趣,值得研究。在这项研究中,从粗粒度分子动力学引导的免疫信息学筛选中鉴定出针对 HLA-A02:01 的五个 CTL 表位。强结合物在结构和能量特性方面表现出与非结合物不同的活性。此外,非九肽的第二个残基在与 HLA-A02:01 的相互作用中最为重要。通过了解 MHC-肽相互作用的性质,我们希望提高找到肽疫苗候选物最佳表位的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d411ea8f11d1/pone.0292156.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/485ce88f76d2/pone.0292156.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/39fa588956a2/pone.0292156.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/3605b7d72356/pone.0292156.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/45cad683690d/pone.0292156.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d372137c5518/pone.0292156.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/2529093b15b0/pone.0292156.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d70f7f0bacb7/pone.0292156.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d411ea8f11d1/pone.0292156.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/485ce88f76d2/pone.0292156.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/39fa588956a2/pone.0292156.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/3605b7d72356/pone.0292156.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/45cad683690d/pone.0292156.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d372137c5518/pone.0292156.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/2529093b15b0/pone.0292156.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d70f7f0bacb7/pone.0292156.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a21f/10553366/d411ea8f11d1/pone.0292156.g008.jpg

相似文献

1
Coarse-grained molecular dynamics-guided immunoinformatics to explain the binder and non-binder classification of Cytotoxic T-cell epitope for SARS-CoV-2 peptide-based vaccine discovery.基于粗粒分子动力学的免疫信息学解释 SARS-CoV-2 肽基疫苗发现中细胞毒性 T 细胞表位的结合子和非结合子分类。
PLoS One. 2023 Oct 5;18(10):e0292156. doi: 10.1371/journal.pone.0292156. eCollection 2023.
2
Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.利用免疫信息学方法阐明针对 SARS-CoV-2 的 C30 内切酶区域的新型化合物和基于表位的肽疫苗设计。
Front Cell Infect Microbiol. 2023 May 24;13:1134802. doi: 10.3389/fcimb.2023.1134802. eCollection 2023.
3
Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.全蛋白质组筛选和鉴定 SARS-CoV-2 的潜在表位用于疫苗设计——一种免疫信息学、分子对接和分子动力学模拟加速的稳健策略。
J Biomol Struct Dyn. 2022 Sep;40(14):6477-6502. doi: 10.1080/07391102.2021.1886171. Epub 2021 Feb 15.
4
3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.基于 3CL 水解酶的 SARS-CoV-2 多表位肽疫苗:免疫信息学方法
J Med Virol. 2020 Oct;92(10):2114-2123. doi: 10.1002/jmv.25993. Epub 2020 May 22.
5
A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.一种基于反向疫苗学和免疫信息学的方法,用于设计针对 SARS-CoV-2 的多表位疫苗。
Immunogenetics. 2021 Dec;73(6):459-477. doi: 10.1007/s00251-021-01228-3. Epub 2021 Sep 20.
6
Identification of SARS-CoV-2 CTL epitopes for development of a multivalent subunit vaccine for COVID-19.鉴定 SARS-CoV-2 CTL 表位,开发用于 COVID-19 的多价亚单位疫苗。
Infect Genet Evol. 2021 Apr;89:104712. doi: 10.1016/j.meegid.2021.104712. Epub 2021 Jan 7.
7
Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.应用高通量和综合免疫信息学方法设计一种三价亚单位疫苗,以诱导针对新型人类冠状病毒 SARS-CoV、MERS-CoV 和 SARS-CoV-2 的免疫反应。
J Biomol Struct Dyn. 2022 Aug;40(13):6097-6113. doi: 10.1080/07391102.2021.1876774. Epub 2021 Jan 29.
8
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.设计针对 SARS-CoV-2 的多表位疫苗:一种免疫信息学方法。
J Biomol Struct Dyn. 2022 Jan;40(1):14-30. doi: 10.1080/07391102.2020.1792347. Epub 2020 Jul 17.
9
Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.基于 SARS-CoV-2 及其变体的免疫信息学方法设计重组多价表位疫苗。
Front Immunol. 2022 May 6;13:884433. doi: 10.3389/fimmu.2022.884433. eCollection 2022.
10
Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.针对 SARS-CoV-2 的多表位疫苗:应用免疫信息学和分子动力学模拟方法。
J Biomol Struct Dyn. 2022 Apr;40(7):2917-2933. doi: 10.1080/07391102.2020.1844060. Epub 2020 Nov 9.

引用本文的文献

1
Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein.鉴定来自 HIV-1 p17 基质蛋白的 HLA-C*03:02 CTL 表位 GY9 的单克隆抗体。
Int J Mol Sci. 2024 Sep 6;25(17):9683. doi: 10.3390/ijms25179683.

本文引用的文献

1
Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach.利用免疫信息学方法设计针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突蛋白(S)和核衣壳蛋白(N)的多表位肽疫苗。
Egypt J Med Hum Genet. 2022;23(1):16. doi: 10.1186/s43042-022-00224-w. Epub 2022 Feb 4.
2
Determinants of latent tuberculosis infection among nurses at public health centers in Indonesia.印度尼西亚公共卫生中心护士潜伏性结核感染的决定因素。
Belitung Nurs J. 2022 Feb 22;8(1):28-34. doi: 10.33546/bnj.1846. eCollection 2022.
3
PANDORA: A Fast, Anchor-Restrained Modelling Protocol for Peptide: MHC Complexes.
PANDORA:一种快速、锚定约束的多肽:MHC 复合物建模方案。
Front Immunol. 2022 May 10;13:878762. doi: 10.3389/fimmu.2022.878762. eCollection 2022.
4
Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.表达严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的痘苗病毒天坛株(MVA)诱导强大免疫力并保护恒河猴免受SARS-CoV-2感染。
Front Immunol. 2022 Mar 16;13:845887. doi: 10.3389/fimmu.2022.845887. eCollection 2022.
5
SARS-CoV-2 variants, immune escape, and countermeasures.SARS-CoV-2 变体、免疫逃逸和对策。
Front Med. 2022 Apr;16(2):196-207. doi: 10.1007/s11684-021-0906-x. Epub 2022 Mar 6.
6
Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach.基于细胞毒性T细胞的抗SARS-CoV-2疫苗:一种混合免疫信息学方法。
Vaccines (Basel). 2022 Jan 30;10(2):218. doi: 10.3390/vaccines10020218.
7
Peptides for Vaccine Development.用于疫苗开发的肽。
ACS Appl Bio Mater. 2022 Mar 21;5(3):905-944. doi: 10.1021/acsabm.1c01238. Epub 2022 Feb 23.
8
The T cell immune response against SARS-CoV-2.针对 SARS-CoV-2 的 T 细胞免疫应答。
Nat Immunol. 2022 Feb;23(2):186-193. doi: 10.1038/s41590-021-01122-w. Epub 2022 Feb 1.
9
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.疫苗引发针对 SARS-CoV-2 奥密克戎的高度保守的细胞免疫。
Nature. 2022 Mar;603(7901):493-496. doi: 10.1038/s41586-022-04465-y. Epub 2022 Jan 31.
10
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.通过感染或接种疫苗,三次接触 SARS-CoV-2 的刺突蛋白会引发对所有令人关注的变异体更好的中和免疫。
Nat Med. 2022 Mar;28(3):496-503. doi: 10.1038/s41591-022-01715-4. Epub 2022 Jan 28.